Basilea Pharmaceutica International Ltd., Allschwil
Manufacturer
www.basilea.com/Allschwil, SwitzerlandAbout
Basilea is a commercial-stage biopharmaceutical company founded in 2000 and headquartered in Switzerland. We are committed to discovering, developing and commercializing innovative drugs to meet the needs of patients with severe bacterial or fungal infections. We have successfully launched two hospital brands, Cresemba for the treatment of invasive fungal infections and Zevtera for the treatment of bacterial infections. In addition, we have preclinical and clinical anti-infective assets in our portfolio. Basilea is listed on the SIX Swiss Exchange (SIX: BSLN). Please visit basilea.com
Pharmacovigilance Operations
Regulatory Affairs & Compliance
Medical Affairs & Patient Safety
Risk Management & Strategy